-
1
-
-
0018691869
-
Platelet-activating factor. Evidence for 1-0-alkyl-2-acetyl-sn-glyceryl- 3-phosphorylcholine as the active component (a new class of lipid chemical mediators)
-
Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl- 3-phosphorylcholine as the active component (a new class of lipid chemical mediators). Demopoulos CA, Pinckard RN, Hanahan DJ, Journal of Biological Chemistry 1979 254 9355 9358 489536 (Pubitemid 10248704)
-
(1979)
Journal of Biological Chemistry
, vol.254
, Issue.19
, pp. 9355-9358
-
-
Demopoulos, C.A.1
Pinckard, R.N.2
Hanahan, D.J.3
-
2
-
-
0036250816
-
The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis
-
The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Zimmerman GA, McIntyre TM, Prescott SM, Stafforini DM, Crit Care Med 2002 30 Suppl 5 294 301
-
(2002)
Crit Care Med
, vol.30
, Issue.SUPPL. 5
, pp. 294-301
-
-
Zimmerman, G.A.1
McIntyre, T.M.2
Prescott, S.M.3
Stafforini, D.M.4
-
3
-
-
0344081893
-
Platelet-Activating Factor, a Pleiotrophic Mediator of Physiological and Pathological Processes
-
Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. Stafforini DM, McIntyre TM, Zimmerman GA, Prescott SM, Crit Rev Cl Lab Sci 2003 40 643 672 10.1080/714037693 (Pubitemid 37491708)
-
(2003)
Critical Reviews in Clinical Laboratory Sciences
, vol.40
, Issue.6
, pp. 643-672
-
-
Stafforini, D.M.1
McIntyre, T.M.2
Zimmerman, G.A.3
Prescott, S.M.4
-
4
-
-
0028982689
-
Platelet-activating factor and its analogs: Metabolic pathways and related intracellular processes
-
7857964
-
Platelet-activating factor and its analogs: metabolic pathways and related intracellular processes. Snyder F, Biochim Biophys Acta 1995 1254 231 249 7857964
-
(1995)
Biochim Biophys Acta
, vol.1254
, pp. 231-249
-
-
Snyder, F.1
-
5
-
-
0033932891
-
Properties and regulation of microsomal PAF-synthesizing enzymes in rat brain cortex
-
DOI 10.1023/A:1007523422825
-
Properties and regulation of microsomal PAF-synthesizing enzymes in rat brain cortex. Francescangeli E, Boila A, Goracci G, Neurochem Res 2000 25 705 713 10.1023/A:1007523422825 10905633 (Pubitemid 30422005)
-
(2000)
Neurochemical Research
, vol.25
, Issue.5
, pp. 705-713
-
-
Francescangeli, E.1
Boila, A.2
Goracci, G.3
-
6
-
-
0031552933
-
CDP-choline: Alkylacetylglycerol cholinephosphotransferase catalyzes the final step in the de novo synthesis of platelet-activating factor
-
DOI 10.1016/S0005-2760(97)00109-4, PII S0005276097001094
-
CDP-choline:alkylacetylglycerol cholinephosphotransferase catalyzes the final step in the de novo synthesis of platelet-activating factor. Snyder F, Biochim Biophys Acta 1997 1348 111 116 9370322 (Pubitemid 27467083)
-
(1997)
Biochimica et Biophysica Acta - Lipids and Lipid Metabolism
, vol.1348
, Issue.1-2
, pp. 111-116
-
-
Snyder, F.1
-
7
-
-
0023278621
-
Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor
-
Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor. Stafforini DM, McIntyre TM, Carter ME, Prescott SM, J Biol Chem 1987 262 4215 4222 3549727 (Pubitemid 17102639)
-
(1987)
Journal of Biological Chemistry
, vol.262
, Issue.9
, pp. 4215-4222
-
-
Stafforini, D.M.1
McIntyre, T.M.2
Carter, M.E.3
Prescott, S.M.4
-
8
-
-
0033771162
-
Role of platelet-activating factor in cardiovascular pathophysiology
-
11015622
-
Role of platelet-activating factor in cardiovascular pathophysiology. Montrucchio G, Alloatti G, Camussi G, Physiol Rev 2000 80 1669 1699 11015622
-
(2000)
Physiol Rev
, vol.80
, pp. 1669-1699
-
-
Montrucchio, G.1
Alloatti, G.2
Camussi, G.3
-
9
-
-
0346849863
-
Platelet activating factor - A molecular link between atherosclerosis theories
-
DOI 10.1002/ejlt.200300845
-
Platelet activating factor-a molecular link between atherosclerosis theories. Demopoulos CA, Karantonis HC, Antonopoulou S, European Journal Of Lipid Science And Technology 2003 105 705 716 10.1002/ejlt.200300845 (Pubitemid 37533028)
-
(2003)
European Journal of Lipid Science and Technology
, vol.105
, Issue.11
, pp. 705-716
-
-
Demopoulos, C.A.1
Karantonis, H.C.2
Antonopoulou, S.3
-
10
-
-
0032893545
-
Potential role of platelet activating factor in acute renal failure
-
DOI 10.1046/j.1523-1755.1999.00450.x
-
Potential role of platelet activating factor in acute renal failure. Lápez-Novoa JM, Kidney Int 1999 55 1672 1682 10.1046/j.1523-1755.1999. 00450.x 10231429 (Pubitemid 29197954)
-
(1999)
Kidney International
, vol.55
, Issue.5
, pp. 1672-1682
-
-
Lopez-Novoa, J.M.1
-
12
-
-
42149083258
-
Platelet-activating factor (PAF): A review of its role in asthma and clinical efficacy of PAF antagonists in the disease therapy
-
DOI 10.2174/187221308783399306
-
Platelet-activating factor (PAF): a review of its role in asthma and clinical efficacy of PAF antagonists in the disease therapy. Kasperska-Zajac A, Brzoza Z, Rogala B, Recent Pat Inflamm Allergy Drug Discov 2008 2 72 76 10.2174/187221308783399306 19075994 (Pubitemid 351524324)
-
(2008)
Recent Patents on Inflammation and Allergy Drug Discovery
, vol.2
, Issue.1
, pp. 72-76
-
-
Kasperska-Zajac, A.1
Brzoza, Z.2
Rogala, B.3
-
13
-
-
0026608812
-
Elevated levels of paf-acether in blood of patients with type 1 diabetes mellitus
-
1563539
-
Elevated levels of paf-acether in blood of patients with type 1 diabetes mellitus. Nathan N, Denizot Y, Huc MC, Claverie C, Laubie B, Benveniste J, Arnoux B, Diabete Metab 1992 18 59 62 1563539
-
(1992)
Diabete Metab
, vol.18
, pp. 59-62
-
-
Nathan, N.1
Denizot, Y.2
Huc, M.C.3
Claverie, C.4
Laubie, B.5
Benveniste, J.6
Arnoux, B.7
-
14
-
-
70349540689
-
The implication of platelet activating factor in cancer growth and metastasis: Potent beneficial role of PAF-inhibitors and antioxidants
-
19689381
-
The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants. Tsoupras AB, Iatrou C, Frangia C, Demopoulos CA, Infect Disord Drug Targets 2009 9 390 399 19689381
-
(2009)
Infect Disord Drug Targets
, vol.9
, pp. 390-399
-
-
Tsoupras, A.B.1
Iatrou, C.2
Frangia, C.3
Demopoulos, C.A.4
-
15
-
-
50249161540
-
Anti-platelet-activating factor effects of highly active antiretroviral therapy (HAART): A new insight in the drug therapy of HIV infection?
-
10.1089/aid.2007.0263 18620493
-
Anti-platelet-activating factor effects of highly active antiretroviral therapy (HAART): a new insight in the drug therapy of HIV infection? Tsoupras AB, Chini M, Tsogas N, Fragopoulou E, Nomikos T, Lioni A, Mangafas N, Demopoulos CA, Antonopoulou S, Lazanas MC, AIDS Res Hum Retroviruses 2008 24 1079 1086 10.1089/aid.2007.0263 18620493
-
(2008)
AIDS Res Hum Retroviruses
, vol.24
, pp. 1079-1086
-
-
Tsoupras, A.B.1
Chini, M.2
Tsogas, N.3
Fragopoulou, E.4
Nomikos, T.5
Lioni, A.6
Mangafas, N.7
Demopoulos, C.A.8
Antonopoulou, S.9
Lazanas, M.C.10
-
16
-
-
0031985470
-
Therapeutic options directed against platelet activating factor, eicosanoids and bradykinin in sepsis
-
Therapeutic options directed against platelet activating factor, eicosanoids and bradykinin in sepsis. Fink MP, J Antimicrob Chemother 1998 41 Suppl A 81 94 9688454 (Pubitemid 28062148)
-
(1998)
Journal of Antimicrobial Chemotherapy
, vol.41
, Issue.SUPPL. A
, pp. 81-94
-
-
Fink, M.P.1
-
17
-
-
33745862736
-
Signaling via platelet-activating factor receptors accounts for the impairment of neutrophil migration in polymicrobial sepsis
-
Signaling via platelet-activating factor receptors accounts for the impairment of neutrophil migration in polymicrobial sepsis. Moreno SE, Alves-Filho JC, Rios-Santos F, Silva JS, Ferreira SH, Cunha FQ, Teixeira MM, J Immunol 2006 177 1264 1271 16818786 (Pubitemid 44036632)
-
(2006)
Journal of Immunology
, vol.177
, Issue.2
, pp. 1264-1271
-
-
Moreno, S.E.1
Alves-Filho, J.C.2
Rios-Santos, F.3
Silva, J.S.4
Ferreira, S.H.5
Cunha, F.Q.6
Teixeira, M.M.7
-
18
-
-
0026323859
-
Involvement of platelet-activating factor (PAF) in septic shock and priming as indicated by the effect of hetrazepinoic PAF antagonists
-
10.1007/BF02536569 1819735
-
Involvement of platelet-activating factor (PAF) in septic shock and priming as indicated by the effect of hetrazepinoic PAF antagonists. Heuer HO, Lipids 1991 26 1369 1373 10.1007/BF02536569 1819735
-
(1991)
Lipids
, vol.26
, pp. 1369-1373
-
-
Heuer, H.O.1
-
19
-
-
0030721009
-
Relevance of platelet-activating factor in inflammation and sepsis: Mechanisms and kinetics of removal in extracorporeal treatments
-
Relevance of platelet-activating factor in inflammation and sepsis: mechanisms and kinetics of removal in extracorporeal treatments. Tetta C, Mariano F, Buades J, Ronco C, Wratten ML, Camussi G, Am J Kidney Dis 1997 30 5 Suppl 4 57 65
-
(1997)
Am J Kidney Dis
, vol.30
, Issue.5 SUPPL. 4
, pp. 57-65
-
-
Tetta, C.1
Mariano, F.2
Buades, J.3
Ronco, C.4
Wratten, M.L.5
Camussi, G.6
-
20
-
-
0028330296
-
Platelet and plasma platelet-activating factor in sepsis and myocardial infarction
-
Platelet and plasma platelet-activating factor in sepsis and myocardial infarction. Graham RM, Strahan ME, Norman KW, Watkins DN, Sturm MJ, Taylor RR, J Lipid Mediat Cell Signal 1994 9 167 182 8012763 (Pubitemid 24107772)
-
(1994)
Journal of Lipid Mediators and Cell Signalling
, vol.9
, Issue.2
, pp. 167-182
-
-
Graham, R.M.1
Strahan, M.E.2
Norman, K.W.3
Watkins, D.N.4
Sturm, M.J.5
Taylor, R.R.6
-
21
-
-
0029939582
-
Platelet activating factor and its role in trauma, shock, and sepsis
-
Platelet activating factor and its role in trauma, shock, and sepsis. Ayala A, Chaudry IH, New Horiz 1996 4 265 275 8774801 (Pubitemid 26171713)
-
(1996)
New Horizons: Science and Practice of Acute Medicine
, vol.4
, Issue.2
, pp. 265-275
-
-
Ayala, A.1
Chaudry, I.H.2
-
22
-
-
0025757009
-
The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure
-
1851337
-
The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure. Anderson BO, Bensard DD, Harken AH, Surg Gynecol Obstet 1991 172 415 424 1851337
-
(1991)
Surg Gynecol Obstet
, vol.172
, pp. 415-424
-
-
Anderson, B.O.1
Bensard, D.D.2
Harken, A.H.3
-
23
-
-
0033994026
-
A double-blind placebo-controlled study of an infusion of lexipafant (platelet-activating factor receptor antagonist) in patients with severe sepsis
-
DOI 10.1128/AAC.44.3.693-696.2000
-
A double-blind placebo-controlled study of an infusion of lexipafant (Platelet-activating factor receptor antagonist) in patients with severe sepsis. Suputtamongkol Y, Intaranongpai S, Smith MD, Angus B, Chaowagul W, Permpikul C, Simpson JA, Leelarasamee A, Curtis L, White NJ, Antimicrob Agents Chemother 2000 44 693 696 10.1128/AAC.44.3.693-696.2000 10681340 (Pubitemid 30117963)
-
(2000)
Antimicrobial Agents and Chemotherapy
, vol.44
, Issue.3
, pp. 693-696
-
-
Suputtamongkol, Y.1
Intaranongpai, S.2
Smith, M.D.3
Angus, B.4
Chaowagul, W.5
Permpikul, C.6
Simpson, J.A.7
Leelarasamee, A.8
Curtis, L.9
White, N.J.10
-
24
-
-
9844237007
-
Platelet-activating factor antagonists
-
Platelet-activating factor antagonists. Negro Alvarez JM, Miralles Lápez JC, Ortiz Martínez JL, Abellán Alemán A, Rubio del Barrio R, Allergol Immunopathol 1997 25 249 258 (Pubitemid 27479856)
-
(1997)
Allergologia et Immunopathologia
, vol.25
, Issue.5
, pp. 249-258
-
-
Negro Alvarez, J.M.1
Miralles Lopez, J.C.2
Ortiz Martinez, J.L.3
Abellan Aleman A, A.4
Rubio Del Barrio, R.5
-
25
-
-
47149099553
-
Characterization of the de novo biosynthetic enzyme of platelet activating factor, DDT-insensitive cholinephosphotransferase, of human mesangial cells
-
17710109
-
Characterization of the de novo biosynthetic enzyme of platelet activating factor, DDT-insensitive cholinephosphotransferase, of human mesangial cells. Tsoupras AB, Fragopoulou E, Nomikos T, Iatrou C, Antonopoulou S, Demopoulos CA, Mediators Inflamm 2007 2007 27683 17710109
-
(2007)
Mediators Inflamm
, vol.2007
, pp. 27683
-
-
Tsoupras, A.B.1
Fragopoulou, E.2
Nomikos, T.3
Iatrou, C.4
Antonopoulou, S.5
Demopoulos, C.A.6
-
26
-
-
33747199084
-
Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis
-
DOI 10.1097/01.shk.0000209562.00070.1a, PII 0002438220060700000009
-
Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis. Gomes RN, Bozza FA, Amncio RT, Japiassú AM, Vianna RC, Larangeira AP, Gouvêa JM, Bastos MS, Zimmerman GA, Stafforini DM, Prescott SM, Bozza PT, Castro-Faria-Neto HC, Shock 2006 26 41 49 16783197 (Pubitemid 44297005)
-
(2006)
Shock
, vol.26
, Issue.1
, pp. 41-49
-
-
Gomes, R.N.1
Bozza, F.A.2
Amancio, R.T.3
Japiassu, A.M.4
Vianna, R.C.S.5
Larangeira, A.P.6
Gouvea, J.M.7
Bastos, M.S.8
Zimmerman, G.A.9
Stafforini, D.M.10
Prescott, S.M.11
Bozza, P.T.12
Castro-Faria-Neto, H.C.13
-
27
-
-
0025334266
-
PAF of biological fluids in disease: I. Levels in blood and urine in cancer
-
PAF of biological fluids in disease: I. Levels in blood and urine in cancer. Demopoulos CA, Koussissis S, Lazanas M, Lakrakis-Lazanas K, Clin Chem Enzymol Commun 1990 3 41
-
(1990)
Clin Chem Enzymol Commun
, vol.3
, pp. 41
-
-
Demopoulos, C.A.1
Koussissis, S.2
Lazanas, M.3
Lakrakis-Lazanas, K.4
-
28
-
-
0027131306
-
Inhibition of cardiolipins of platelet-activating factor-induced rabbit platelet activation
-
DOI 10.1007/BF02537080
-
Inhibition of cardiolipins of platelet-activating factor-induced rabbit platelet activation. Tsoukatos D, Demopoulos CA, Tselepis AD, Moschidis MC, Donos A, Evangelou A, Benveniste J, Lipids 1993 28 1119 1124 10.1007/BF02537080 8121255 (Pubitemid 24009787)
-
(1993)
Lipids
, vol.28
, Issue.12
, pp. 1119-1124
-
-
Tsoukatos, D.1
Demopoulos, C.A.2
Tselepis, A.D.3
Moschidis, M.C.4
Donos, A.5
Evangelou, A.6
Benveniste, J.7
-
29
-
-
33845261493
-
A rapid method of total lipid extraction and purification
-
10.1139/o59-099 13671378
-
A rapid method of total lipid extraction and purification. Bligh EG, Dyer WJ, Can J Biochem Physiol 1959 37 911 917 10.1139/o59-099 13671378
-
(1959)
Can J Biochem Physiol
, vol.37
, pp. 911-917
-
-
Bligh, E.G.1
Dyer, W.J.2
-
30
-
-
0028168481
-
Platelet-activating factor acetylhydrolase (PAF-AH) in human kidney
-
10.1016/0020-711X(94)90138-4 7988740
-
Platelet-activating factor acetylhydrolase (PAF-AH) in human kidney. Antonopoulou S, Demopoulos CA, Iatrou C, Moustakas G, Zirogiannis P, Int J Biochem 1994 26 1157 1162 10.1016/0020-711X(94)90138-4 7988740
-
(1994)
Int J Biochem
, vol.26
, pp. 1157-1162
-
-
Antonopoulou, S.1
Demopoulos, C.A.2
Iatrou, C.3
Moustakas, G.4
Zirogiannis, P.5
-
31
-
-
0017184389
-
A rapid and sensitive method for the quantization of microgram quantities of protein utilizing the principle of protein-dye binding
-
10.1016/0003-2697(76)90527-3 942051
-
A rapid and sensitive method for the quantization of microgram quantities of protein utilizing the principle of protein-dye binding. Bradford MM, Anal Biochem 1976 72 248 254 10.1016/0003-2697(76)90527-3 942051
-
(1976)
Anal Biochem
, vol.72
, pp. 248-254
-
-
Bradford, M.M.1
-
32
-
-
77949303559
-
The coagulant response in sepsis and inflammation
-
14-16 20162247
-
The coagulant response in sepsis and inflammation. Levi M, Hamostaseologie 2010 30 10 12 14-16 20162247
-
(2010)
Hamostaseologie
, vol.30
, pp. 10-12
-
-
Levi, M.1
-
33
-
-
65249119361
-
Lipid mediators in health and disease: Enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation
-
10.1146/annurev.pharmtox.011008.145616 18834304
-
Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Shimizu T, Annu Rev Pharmacol Toxicol 2009 49 123 150 10.1146/annurev.pharmtox.011008. 145616 18834304
-
(2009)
Annu Rev Pharmacol Toxicol
, vol.49
, pp. 123-150
-
-
Shimizu, T.1
-
34
-
-
70350398248
-
Crosstalk between protease-activated receptor 1 and platelet activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression andmelanomametastasis
-
10.1074/jbc.M109.042150 19703903
-
Crosstalk between protease-activated receptor 1 and platelet activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression andmelanomametastasis. Melnikova VO, Balasubramanian K, Villares GJ, Dobroff AS, Zigler M, Wang H, Petersson F, Price JE, Schroit A, Prieto VG, Hung MC, Bar-Eli M, Journal of Biological Chemistry 2009 284 28845 28855 10.1074/jbc.M109.042150 19703903
-
(2009)
Journal of Biological Chemistry
, vol.284
, pp. 28845-28855
-
-
Melnikova, V.O.1
Balasubramanian, K.2
Villares, G.J.3
Dobroff, A.S.4
Zigler, M.5
Wang, H.6
Petersson, F.7
Price, J.E.8
Schroit, A.9
Prieto, V.G.10
Hung, M.C.11
Bar-Eli, M.12
-
35
-
-
65549085700
-
Inflammation and melanoma metastasis
-
10.1111/j.1755-148X.2009.00570.x 19368690
-
Inflammation and melanoma metastasis. Melnikova VO, Bar-Eli M, Pigment Cell and Melanoma Research 2009 22 257 267 10.1111/j.1755-148X.2009.00570.x 19368690
-
(2009)
Pigment Cell and Melanoma Research
, vol.22
, pp. 257-267
-
-
Melnikova, V.O.1
Bar-Eli, M.2
-
36
-
-
0025216417
-
Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia
-
Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia. Fletcher JR, DiSimone AG, Earnest MA, Ann Surg 1990 211 312 316 2178565 (Pubitemid 20105984)
-
(1990)
Annals of Surgery
, vol.211
, Issue.3
, pp. 312-316
-
-
Fletcher, J.R.1
Disimone, A.G.2
Earnest, M.A.3
-
37
-
-
0041431065
-
1 receptor and platelet-activating factor (PAF) antagonist - A review of pharmacological profile and clinical management of allergic rhinitis
-
DOI 10.1358/dot.2003.39.6.799450
-
Rupatadine: a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and clinical management of allergic rhinitis. Izquierdo I, Merlos M, García-Rafanell J, Drugs Today 2003 39 451 468 10.1358/dot.2003.39.6.799450 12944997 (Pubitemid 37039398)
-
(2003)
Drugs of Today
, vol.39
, Issue.6
, pp. 451-468
-
-
Izquierdo, I.1
Merlos, M.2
Garcia-Rafanell, J.3
|